(Q92242280)

English

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

scientific article published on 01 January 2020

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit